Prevention and Treatment for Covid-19 Assoiated Severe Pnuemonia in The Gambia: A randomized clinical Trial - Funded by UKRI
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: C19-IUC-112
Grant search
Key facts
Disease
COVID-19Funder
UK Research and Innovation (UKRI)Principal Investigator
Professor Anna RocaResearch Location
GambiaLead Research Institution
MRC Unit The Gambia at the London School of Hygiene & Tropical MedicineResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Supportive care, processes of care and management
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Randomized Controlled Trial
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The study intends to evaluate the efficacy of a chosen drug in preventing progression to severe pneumonia, and to evaluate the efficacy of prophylactic chosen drug in preventing COVID19 infection among house hold contacts (both symptomatic and asymptomatic).